HRAS

HRAS
Identifiers
AliasesHRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras, Harvey rat sarcoma viral oncogene homolog, HRas proto-oncogene, GTPase, RASK2
External IDsOMIM: 190020; MGI: 96224; GeneCards: HRAS
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
3.6.5.2↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

3265

15461

Ensembl

ENSG00000276536
ENSG00000174775

ENSMUSG00000025499

UniProt

P01112

Q61411

RefSeq (mRNA)

NM_001130442
NM_005343
NM_176795
NM_001318054

NM_001130443
NM_001130444
NM_008284

RefSeq (protein)

NP_001123914
NP_001304983
NP_005334
NP_789765

NP_001123915
NP_001123916
NP_032310

Location (UCSC)Chr 11: 0.53 – 0.54 MbChr 7: 140.77 – 140.77 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

GTPase HRas, also known as the "Harvey Rat sarcoma viral oncogene homolog" and transforming protein p21, is an enzyme that is encoded by the HRAS gene in humans. The HRAS gene is located on the short (p) arm of chromosome 11 at position 15.5, from base pair 522,241 to base pair 525,549. HRas is a small G protein in the Ras subfamily of the Ras superfamily of small GTPases. Once bound to guanosine triphosphate, H-Ras will activate a Raf kinase like c-Raf, the next step in the MAPK/ERK pathway.

The gene was initially discovered in the Harvey rat sarcoma virus as a viral oncogene (Harvey murine sarcoma virus, Gammaretrovirus Hamursar), hence its name. The gene carried by this virus was later discovered to closely resemble a normal cellular gene found in many animals. From this, it was deduced that the virus had captured this cellular gene at some point in its evolutionary history. Once incorporated, the gene gave the virus the capability to disrupt normal cell growth, turning it into an oncovirus. Incorporation of cellular genes happens regularly in retroviruses; when a key regulatory gene such as HRAS is incorporated, it may become oncogenic as the virus continues to evolve. The benign version in the cellular genome is not directly cancerous, but further mutations can turn it cancerous. As a result, the cellular version is called a proto-oncogene.